Medicare Enrolled
Dr. Neeharika Makani, M.D.
Hematology & Oncology · Largo, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Makani from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Makani?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Makani
Dr. Neeharika Makani is a hematology & oncology specialist in Largo, FL, with 17 years of NPI registration. Based on federal Medicare data, Dr. Makani performed 27,186 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Makani received a total of $14,084 from 75 pharmaceutical and/or device companies across 615 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Makani is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years of NPI registration
▲ Top 21% volume in FL
$14,084 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 125481 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗27,186
Medicare services
Top 21% in FL for hematology & oncology
Not available
Unique patients (not deduplicated)
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
19,890 | $0 | $1 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
3,040 | $6 | $19 |
| Denosumab injection (Prolia/Xgeva) | 1,680 | $18 | $59 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
716 | $0 | $1 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
332 | $8 | $18 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
311 | $8 | $23 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
275 | $95 | $310 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
128 | $22 | $68 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
119 | $48 | $151 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
107 | $10 | $34 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
103 | $10 | $32 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
94 | $12 | $37 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
83 | $99 | $307 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
81 | $1 | $3 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
63 | $13 | $34 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
38 | $95 | $293 |
| New patient office visit, complex (60-74 min) | 31 | $171 | $537 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
28 | $65 | $219 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
27 | $134 | $427 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
26 | $51 | $171 |
| Iron level test | 14 | $6 | $16 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
74.4% high complexity
21.1% medium
4.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$14,084
Total received (2019-2024)
Avg $2,347/year across 6 years
Top 32% in FL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
75
Companies
615
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,775
2023
$4,138
2022
$3,500
2021
$1,197
2020
$457
2019
$17
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$1,149
PFIZER INC.
$455
Janssen Biotech, Inc.
$270
E.R. Squibb & Sons, L.L.C.
$240
Merck Sharp & Dohme LLC
$234
Lilly USA, LLC
$215
Daiichi Sankyo Inc.
$208
Celgene Corporation
$207
Regeneron Healthcare Solutions, Inc.
$156
AstraZeneca Pharmaceuticals LP
$139
Fennec Pharmaceuticals, Inc.
$121
GlaxoSmithKline, LLC.
$118
TAIHO ONCOLOGY, INC.
$113
Bayer Healthcare Pharmaceuticals Inc.
$89
Genentech USA, Inc.
$77
Gilead Sciences, Inc.
$77
ARRAY BIOPHARMA INC
$75
Genmab U.S., Inc.
$72
Tempus AI, Inc
$63
SOBI, INC
$60
Sumitomo Pharma America, Inc.
$46
Agios Pharmaceuticals, Inc.
$46
Astellas Pharma US Inc
$41
Exelixis Inc.
$38
ABBVIE INC.
$37
Takeda Pharmaceuticals U.S.A., Inc.
$31
Emmaus Medical, Inc.
$30
Janssen Scientific Affairs, LLC
$28
Incyte Corporation
$27
Stemline Therapeutics Inc.
$26
Eisai Inc.
$25
Telix Pharmaceuticals
$25
Rigel Pharmaceuticals, Inc.
$24
Boehringer Ingelheim Pharmaceuticals, Inc.
$22
PUMA BIOTECHNOLOGY, INC.
$22
SERVIER PHARMACEUTICALS LLC
$22
Janssen Pharmaceuticals, Inc
$22
Aveo Pharmaceuticals, Inc.
$20
Karyopharm Therapeutics Inc.
$18
Kyowa Kirin, Inc.
$18
Pharmacosmos Therapeutics Inc.
$18
Myriad Genetic Laboratories, Inc.
$17
Alexion Pharmaceuticals, Inc.
$17
JAZZ PHARMACEUTICALS INC.
$15
Top 3 companies account for 39.2% of 2024 payments
All-time payments by company (2019-2024) ›
Novartis Pharmaceuticals Corporation
$2,334
Lilly USA, LLC
$854
PFIZER INC.
$842
Daiichi Sankyo Inc.
$802
AstraZeneca Pharmaceuticals LP
$788
Merck Sharp & Dohme LLC
$638
Janssen Biotech, Inc.
$541
E.R. Squibb & Sons, L.L.C.
$458
Regeneron Healthcare Solutions, Inc.
$445
Seagen Inc.
$333
Genentech USA, Inc.
$322
NOVARTIS PHARMACEUTICALS CORPORATION
$313
Celgene Corporation
$310
Astellas Pharma US Inc
$297
Amgen Inc.
$233
ARRAY BIOPHARMA INC
$218
Gilead Sciences, Inc.
$212
Karyopharm Therapeutics Inc.
$204
Exelixis Inc.
$191
Incyte Corporation
$185
Takeda Pharmaceuticals U.S.A., Inc.
$158
GENZYME CORPORATION
$155
SOBI, INC
$153
Kite Pharma, Inc.
$148
Stemline Therapeutics Inc.
$147
GlaxoSmithKline, LLC.
$147
TAIHO ONCOLOGY, INC.
$131
Myriad Genetic Laboratories, Inc.
$124
PUMA BIOTECHNOLOGY, INC.
$121
Fennec Pharmaceuticals, Inc.
$121
Eisai Inc.
$111
Bayer Healthcare Pharmaceuticals Inc.
$110
Boehringer Ingelheim Pharmaceuticals, Inc.
$105
Pharmacosmos Therapeutics Inc.
$105
Intuitive Surgical, Inc.
$99
AVEO Pharmaceuticals, Inc.
$97
CTI BioPharma Corp.
$85
Sumitomo Pharma America, Inc.
$85
Pharmacyclics LLC, An AbbVie Company
$85
Janssen Pharmaceuticals, Inc
$76
Genmab U.S., Inc.
$72
JAZZ PHARMACEUTICALS INC.
$67
Tempus AI, Inc
$63
Merck Sharp & Dohme Corporation
$60
Global Blood Therapeutics, Inc.
$60
Alexion Pharmaceuticals, Inc.
$52
Kyowa Kirin, Inc.
$49
Sun Pharmaceutical Industries Inc.
$46
Agios Pharmaceuticals, Inc.
$46
Pharmacyclics LLC, an AbbVie Company
$44
Sobi, Inc
$42
Myovant Sciences Inc.
$39
Heron Therapeutics, Inc.
$39
ABBVIE INC.
$37
MorphoSys, US Inc.
$34
Acrotech Biopharma LLC
$31
Emmaus Medical, Inc.
$30
Janssen Scientific Affairs, LLC
$28
EMD Serono, Inc.
$25
EISAI INC.
$25
EUSA Pharma (US) LLC
$25
Telix Pharmaceuticals
$25
GE HEALTHCARE
$24
Rigel Pharmaceuticals, Inc.
$24
SERVIER PHARMACEUTICALS LLC
$22
Kedrion Biopharma, Inc.
$22
Alnylam Pharmaceuticals Inc.
$22
Servier Pharmaceuticals LLC
$21
Aveo Pharmaceuticals, Inc.
$20
Puma Biotechnology, Inc.
$19
SUN PHARMACEUTICAL INDUSTRIES INC.
$19
AMAG Pharmaceuticals, Inc.
$19
Organon LLC
$19
AbbVie Inc.
$16
Mirati Therapeutics, Inc.
$15
Top 3 companies account for 28.6% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · ALUNBRIG · AUGTYRO · Albuked · BAVENCIO · BELEODAQ · BOSULIF · BRAFTOVI · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · CINVANTI · CYRAMZA · Cabometyx · Columvi · DARZALEX · DOPTELET · Da Vinci Surgical System · Doptelet · ELITEK · ELREXFIO · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · Endari · Enhertu · Epkinly · FERAHEME · FOTIVDA · Fabhalta · GAZYVA · GILOTRIF · GIVLAARI · Gazyva · IBRANCE · ICLUSIG · ILLUCCIX · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · JAKAFI · JEMPERLI · KEYTRUDA · KISQALI · KRAZATI · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MYRISK · NERLYNX · NINLARO · Nplate · Nubeqa · OJJAARA · ONTRUZANT · OPDIVO · ORGOVYX · OXBRYTA · Odomzo · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · Padcev · Pedmark · Perjeta · Phesgo · Poteligeo · PreciseTumor · REBLOZYL · RETEVMO · Rezlidhia · SARCLISA · SCEMBLIX · SUSTOL · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tibsovo · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · Venclexta · Vonjo · XARELTO · XGEVA · XPOVIO · XTANDI · Xospata · Xtandi · YONSA · Yescarta · ZEPZELCA · ZIIHERA · myRisk
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
102
County median income
$70,293
Nearest hospital to ZIP centroid (approximate)
HCA FLORIDA LARGO HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Makani is a mixed practice specialist, with above-average Medicare volume (top 21% in FL), with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Makani experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Makani performed 19,890 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Makani receive payments from pharmaceutical companies?
Yes. Dr. Makani received a total of $14,084 from 75 companies across 615 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Makani's costs compare to other hematology & oncology specialists in Largo?
Dr. Makani's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Makani) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Largo
Browse hematology & oncology specialists in Largo ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in FL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in FL
Which FL hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology